II. Indications
-
Atrial Fibrillation Cardioversion
- Time to Cardioversion: 3-6h
- Conversion Rate: 38-86%
- Chronic Efficacy: 47-60%
III. Mechanism
- Class Ia Antiarrhythmic
IV. Dosing
- Dose: 324-648 mg PO q8h